Insomnia treatment goes OTC

Modified-release melatonin downscheduled to Pharmacist Only from 1 June Modified-release melatonin has been downscheduled to Schedule 3 (Pharmacist Only) for the treatment of primary insomnia from 1 June 2021. The decision is restricted to short-term monotherapy in people aged 55 or over, with tablets containing 2mg or less in packs up to 30 tablets. Currently